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We have previously reported that actin filaments are involved in protein transport from the Golgi
complex to the endoplasmic reticulum. Herein, we examined whether myosin motors or actin
comets mediate this transport. To address this issue we have used, on one hand, a combination of
specific inhibitors such as 2,3-butanedione monoxime (BDM) and 1-[5-isoquinoline sulfonyl]-2-
methyl piperazine (ML7), which inhibit myosin and the phosphorylation of myosin II by the
myosin light chain kinase, respectively; and a mutant of the nonmuscle myosin II regulatory light
chain, which cannot be phosphorylated (MRLC2AA). On the other hand, actin comet tails were
induced by the overexpression of phosphatidylinositol phosphate 5-kinase. Cells treated with
BDM/ML7 or those that express the MRLC2AA mutant revealed a significant reduction in the
brefeldin A (BFA)-induced fusion of Golgi enzymes with the endoplasmic reticulum (ER). This
delay was not caused by an alteration in the formation of the BFA-induced tubules from the Golgi
complex. In addition, the Shiga toxin fragment B transport from the Golgi complex to the ER was
also altered. This impairment in the retrograde protein transport was not due to depletion of
intracellular calcium stores or to the activation of Rho kinase. Neither the reassembly of the Golgi
complex after BFA removal nor VSV-G transport from ER to the Golgi was altered in cells treated
with BDM/ML7 or expressing MRLC2AA. Finally, transport carriers containing Shiga toxin did
not move into the cytosol at the tips of comet tails of polymerizing actin. Collectively, the results
indicate that 1) myosin motors move to transport carriers from the Golgi complex to the ER along
actin filaments; 2) nonmuscle myosin II mediates in this process; and 3) actin comets are not
involved in retrograde transport.
INTRODUCTION
Actin filaments are crucial for cell migration and the
maintenance of cellular morphology. In addition, a role
for actin in membrane trafficking is emerging for both the
endocytic and the secretory pathway (for recent reviews,
see DePina and Langford, 1999; De Matteis and Morrow,
2000; Qualmann et al., 2000; Apodaca, 2001; May and
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Machesky, 2001; Stamnes, 2002). Although the role of
actin in the secretory pathway has long been elusive, a
breakthrough in our understanding has come with the use
of highly specific inhibitors of actin polymerization, such
as latrunculins and botulinum C2 toxin. Thus, actin fila-
ments play a significant role in basolateral and Golgi-to-
endoplasmic reticulum (ER) protein transport in polar-
ized and nonpolarized mammalian cells, respectively
(Mu¨sch et al., 1997, 2001; Valderrama et al., 2000, 2001).
Additional results that substantiated the involvement of
actin in membrane trafficking in mammalian cells stem
from the presence of members of myosin superfamily in
organelle and vesicle transport in the secretory and endo-
cytic pathways. For example, myosin V transports ER-
derived vesicles in nerve cells (Tabb et al., 1998) and
interacts with synaptic vesicle proteins (Prekeris and Ter-
rian, 1997; Miller and Sheetz, 2000); myosin I was initially
detected in isolated Golgi fractions and vesicles (Fath and
Burgess, 1993; Fath et al., 1994; Montes de Oca et al., 1997),
although it seems to be functionally and structurally in-
volved in the endocytic pathway (Cordonnier et al., 2001,
and references therein); myosin VI has been localized in
the Golgi complex (Buss et al., 1998) but to date has only
been shown to be functionally involved in clathrin-medi-
ated endocytosis (Buss et al., 2001); and finally, myosin II
has been implicated in the formation of and immunolo-
calized in trans-Golgi– derived transport carriers (Narula
and Stow, 1995; Ikonen et al., 1996, 1997; Ecay et al., 1997;
Mu¨sch et al., 1997; Heimann et al., 1999), although with
controversial results (Simon et al., 1998; Stow et al., 1998).
Taken together, these results suggest that myosins are
involved in intracellular trafficking by binding to subcel-
lular compartments and generating force, either in the
formation or the movement of vesicular carriers.
Until recently, the only known mechanism by which
membrane structures moved along actin tracks was the
myosin motors. However, the molecular mechanisms for
the intracellular movement of certain pathogens through
the formation of actin comets (for recent reviews, see
Cossart, 2000; Goldberg, 2001) have also been observed in
secretory and endocytic vesicles (Merrifield et al., 1999,
2001; Rozelle et al., 2000; Taunton et al., 2000; Orth et al.,
2002; Benesch et al., 2002; Lee and De Camilli, 2002). An
actin comet is a characteristic structure easily visible by
light microscopy, which results from a focalized actin
polymerization (the tail) onto endomembranes and that
acts as a driving force to propel them through the cyto-
plasm (for review, see Taunton, 2001). Vesicle rocketing
basically requires N-WASP and Arp2/3 (Rozelle et al.,
2000; Benesch et al., 2002). We have recently reported that
N-WASP/Arp2/3 regulates Golgi-to-ER protein transport
(Luna et al., 2002), and, therefore, it is possible that actin
comets propel Golgi-to-ER transport carriers (for review,
see Ridley, 2001).
Herein, we examine whether myosin motors, which exert
force against actin filaments, move these Golgi-to-ER trans-
port carriers or, in contrast, they are propelled by actin
comets, as occurs with some pathogens. The results indicate
that only myosin motors move to transport carriers along
actin filaments in the Golgi-to-ER pathway. In addition, we
provide direct evidence that nonmuscle myosin II is in-
volved in this process.
MATERIALS AND METHODS
Materials
Cy3-tagged native Shiga toxin fragment B was obtained from
Ludger Johannes and Bruno Goud (Institute Curie, Paris, France;
Johannes et al., 1997). The plasmid encoding myc-tagged mouse
PIP5-KI (PIP5K) was from Laura M. Machesky (University of
Birmingham, Birmingham, United Kingdom; Rozelle et al., 2000),
and the plasmids encoding myc-tagged MRLC2 wild-type (MRL-
Cwt) and nonphosphorylated (MRLC2AA) forms were generated by
site-directed mutagenesis by using polymerase chain reaction as
described previously (Iwasaki et al., 2001). Antibodies against the
myc-epitope were from 9E10 hybridoma, and those to Golgi-resi-
dent proteins giantin, mannosidase II, and galactosyltransferase
were supplied by H.-P. Hauri (Biozentrum, Basel, Switzerland), K.
Moremen (University of Georgia, Athens, GA), and E. Berger (Uni-
versity of Zu¨rich, Zu¨rich, Switzerland), respectively. DMEM and
fetal calf serum (FCS) were from Invitrogen (Paisley, UK); second-
ary Alexa-488 or Alexa-546 F(ab)2 fragments, cascade blue dextran,
tetramethylrhodamine B isothiocyanate (TRITC)-dextran (10,000
mol. wt.), Fluo-4/acetoxymethyl ester (AM), and Pluronic F-127
were from Molecular Probes (Leiden, The Netherlands); 2,3-butane-
dione monoxime (BDM) was purchased from Sigma-Aldrich (St.
Louis, MO); and Mowiol, thapsigargin, 1-[5-isoquinoline sulfonyl]-
2-methyl piperazine (ML7), H7, and H89 were from Calbiochem
(Nottingham, United Kingdom). Of note, BDM was reconstituted in
DMEM (concentrated stock of 250 mM), H7 (10 mM) in distilled
water, and ML7 and H89 (10 mM each) in a mixed solution of
distilled water and ethanol (1:1). Unless otherwise stated, all other
chemicals were from Sigma-Aldrich.
Cell Culture
HeLa and normal rat kidney (NRK) cells were cultured in DMEM
containing 10% FCS supplemented with 10 mM l-glutamine, peni-
cillin (100 U/ml), and streptomycin (100 g/ml). Cells were grown
in a humidified incubator at 37°C and 5% CO2.
Microinjection Experiments
For microinjection, HeLa and NRK cells were grown for 1–2 d on
normal glass coverslips and cultured in DMEM plus 10% FCS
containing 25 mM HEPES, and supplemented with penicillin, strep-
tomycin, and glutamine. Myc-tagged PIP5K cDNA constructs were
first diluted to 50 ng/ml and then microinjected into the cell nucleus
with an automated microinjection system (Carl Zeiss, Jena, Germa-
ny). After microinjection, the coverslips were transferred to a Petri
dish containing fresh culture medium and returned to the incubator.
Expression of Recombinant MRLC2
HeLa cells were transfected using Superfect reagent (QIAGEN,
Valencia, CA) following the protocol indicated by the manufacturer.
Briefly, cells plated on p35 culture Petri dishes were incubated for
2 h with MRLC2wt or MRLC2AA cDNAs (2 g) previously mixed
with Superfect in DMEM containing 10% of FCS. Subsequently, cells
were washed and cultured in DMEM for 16–24 h.
Intracellular Calcium Measurements
NRK cells were plated onto glass-bottom dishes (Delta T culture
dishes; Bioptechs, Butler, PA). After 1 d of culture, cells were rinsed
three times with loading buffer (Hanks balanced salt solution with
10 mM d-glucose, 1.3 mM CaCl2, and 1.1 mM MgCl2) and loaded
with Fluo-4/AM (4 M) dissolved in loading buffer containing 0.4%
Pluronic for 15 min at 37°C in a 5% CO2 atmosphere. Cells were then
washed in loading buffer and incubated in DMEM for 30 min at
room temperature to allow complete deesterification of intracellular
AM ester. All calcium measurement experiments were carried out at
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37°C (Delta T; Bioptechs) adapted to an inverted TCS 4D confocal
microscope (Leica Microsystems, Heidelberg, Germany). Images
were taken with a Plan Apochromatic 40/1.3 oil objective by using
the Ion Domain Quantify software from Leica Microsystems. Re-
gions of Interest (ROIs) were set for each cell. Background-sub-
tracted, fluorescence signals of each ROI were corrected for the
bleaching of the Fluo-4 fluorescence signal and the mean fluores-
cence intensity of each ROI was calculated. Changes in the intracel-
lular calcium concentration ([Ca2]i) are given as the relative change
in the fluorescence ratio F/F0 of Fluo-4/AM, where F is the fluo-
rescence intensity at any time, and F0 is the baseline fluorescence
intensity, as described previously (Bootman et al., 1997; Heemskerk
et al., 2001). Values are expressed as the mean  S.E. of the normal-
ized fluorescence (F/F0). Data were obtained from 8 to 30 cells.
VSV-G and Shiga Toxin Transport Assays
Infection with the temperature-sensitive (ts) mutant ts045 VSV was
performed as described previously (Valderrama et al., 1998). Indi-
rect immunofluorescence transport of VSV-G from ER-to-Golgi
complex was performed following Bonatti et al. (1989).
For the Shiga toxin (ST-B-KDEL) transport experiments, HeLa
cells were first incubated in binding medium (FCS-free DMEM) and
treated with cy3-ST-B-KDEL-fragment for 30 min at 4°C, and the
unbound toxin was then washed for 5 min in ice-cold phosphate-
buffered saline. Thereafter, cells were incubated with DMEM at
20°C for 2 h to accumulate the internalized ST-B-KDEL in early/
recycling endosomes. They were then transferred to 37°C to syn-
chronize the ST-B-KDEL transport to the ER via the Golgi complex.
Indirect Immunofluorescence
Indirect immunofluorescence was carried out as described previ-
ously (Valderrama et al., 1998, 2000) with the following antibody
dilutions: anti--coatomer protein (COP), 1:60; anti-mannosidase II,
1:2000; anti-myc, 1:100; anti-galactosiltransferase, 1:500; anti-giantin,
1:500; anti-VSV-G, 1:50, and Alexa 488- and 546-conjugated second-
ary antibodies, 1:500 and 1:1000, respectively. TRITC- or coumarin-
phalloidin were used to stain F-actin, at a dilution of 1:1000 and
1:100, respectively. The coverslips were mounted on microscope
slides using Mowiol. Microscopy and imaging were performed with
a BX60 epifluorescence microscope with a chilled DP-50 charge-
coupled device camera (Olympus, Tokyo, Japan) or a TCS-NT con-
focal microscope (Leica Microsystems). The images were processed
on PC computers using Adobe Photoshop 5.0.
Electron Microscopy and Stereological Analyses
Cells were washed twice in 100 mM cacodylate buffer (pH 7.2) and
fixed with 2.5% glutaraldehyde in this buffer for 60 min at room
temperature. Cells were then washed (3 5 min each) in cacodylate
buffer and postfixed with 1% (vol/vol) OsO4/1.5% (wt/vol)
K4Fe(CN)6 in 100 mM cacodylate buffer for 1 h at 4°C. Cells were
scraped, pelleted, and treated for 1 h at 4°C with 1% tannic acid in
cacodylate buffer, rinsed in distilled water, and stained en bloc with
1% aqueous uranyl acetate for 1 h, followed by dehydration through
graded ethanol solutions and embedding in Epon 812. Ultrathin
sections were stained with lead citrate for 2 min and observed in a
301 electron microscope (Philips, Eindhoven, The Netherlands).
Randomly selected micrographs were taken at the same final mag-
nification (47,500) and analyzed using point-counting procedures.
The Golgi complex (GC) was defined as a group of cisternae orga-
nized in stacks with tubular and vesicular structures. Total Golgi
complex (tGC) was defined as an area containing at least one
cisterna and peri-Golgi vesicles, with an arbitrary border in the
cytoplasm surrounding the Golgi (Renau-Piqueras et al., 1987). In-
termediate elements in continuity with the rough ER were excluded.
The stereological parameters were determined using standard pro-
cedures (Renau-Piqueras et al., 1987). The minimum sample size
(number of micrographs; Table 1) of each stereological parameter
was determined by the progressive mean technique (confidence
limit of 5%). The results were expressed as means  SD and com-
pared using the Student’s t test.
RESULTS
Myosin Inhibition Alters the Golgi Complex
Morphology
To determine whether actin-dependent motors govern
membrane dynamics at the ER/Golgi interface, we first used
BDM as a broad-spectrum inhibitor of both conventional
and unconventional myosin Mg2-ATPase activity (Higuchi
and Takemori, 1989; Herrmann et al., 1992; Cramer and
Mitchison, 1995; Lin et al., 1996). At fluorescence level, NRK
cells treated with BDM at concentrations ranging from 5 to
20 mM showed no change in the Golgi complex morphology
in comparison with untreated control cells (Figure 1, A and
C), but at higher concentrations (30 and 40 mM) the Golgi
complex showed a more compact morphology (Figure 1E).
Actin stress fibers were virtually unaltered when cells were
treated with BDM from 5 to 20 mM (Figure 1D), but they
diminished in number when it was used at 40 mM (Figure
1F).
Because myosin II, a major actin-based motor protein, has
been implicated in the formation of transport vesicles at the
trans-Golgi network (TGN) level (Mu¨sch et al. 1997; Stow et
al., 1998), we then examined the effect of ML7, a compound
that inhibits myosin light chain kinase (MLCK) function,
Table 1. Stereological analysis of the Golgi complex in control and BDM- or ML7-treated NRK cells
Control
BDM ML7
20 mM 40 mM 15 M 30 M
Vv tGC/cyt 3.9  2.7 17  4.3 23  5.4 19.4  6.3 21.3  8
Vv cist/cyt 48.8  7.6 60.4  10 58.4  10 60.1  12.1 68  11.2
Sv cist/tGC 9.3  2.7 8  3.1* 5  1.2 4.8  1 4.9  1
Vv ves/tGC 3.0  0.8 6.2  2 5.8  2.2 7.8  3.3 14  3.3
N 40 47 43 44 44
Vv: volume density (%); Sv: surface density (m1); Cist: Golgi cisternae; ves: per-Golgi vesicular structures. cyt: cytoplasm; N, number of
cells analyzed. All values are statistically significant (p  0.05) except where indicated respect to control cells (*).
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thus specifically preventing myosin II activation via phos-
phorylation (Saitoh et al., 1987). When NRK cells were
treated with ML7 at concentrations of 15 and 30 M, the
Golgi complex was perinuclear but, instead of showing its
continuous reticular shape characteristic of untreated NRK
cells (Figure 1A), a pearl necklace-like morphology was
observed (Figure 1G). Furthermore, ML7 also decreased ac-
tin stress fibers (Lamb et al., 1988) and produced numerous
actin-stained cytoplasmic spots (Figure 1H).
To determine the site and mode of action of BDM and
ML7, an ultrastructural (Figure 2) and stereological analysis
(Table 1) of the Golgi complex was performed. BDM at 20 or
40 mM induced severe changes in the Golgi ultrastructure,
the cisternae seeming swollen (Figure 2B). BDM increased
the volume occupied by the tGC in the cytoplasm (Vv tGC/
cyt; Table 1). This could be attributable to an increase either
in the volume of Golgi cisternae (Vv cist/tGC) or in the
volume of peri-Golgi vesicular structures (Vv ves/tGC). At
the electron microscopic (EM) level, the former is visualized
as swollen cisternae (Figure 2B) and the latter results from
the decrease in the Golgi membrane surface density (Sv
cist/tGC). In cells treated with ML-7 (15 and 30 M), similar
results were obtained regardless of the concentration used,
but the decrease in the Golgi membrane surface density (Sv
cist/tGC) was greater. As expected, this was followed by a
much higher volume density of peri-Golgi vesicular struc-
tures (Vv ves/tGC), which at the EM level are viewed as
numerous vesicular structures of uniform size closely at-
tached to Golgi cisternae (Figure 2C).
Inhibition of Myosin Function Alters the
Retrograde, but Not the Anterograde, Protein
Transport
Because actin filaments facilitate retrograde transport from
the Golgi complex to the endoplasmic reticulum (Valder-
rama et al., 2001), we next studied whether myosin activation
is required in ER/Golgi membrane dynamics. We first ex-
amined whether these antimyosin agents (BDM and ML7)
alter the disassembly of the Golgi complex induced by
brefeldin A (BFA) (Figure 3). NRK or HeLa cells were first
treated with BDM and then with BFA for different times.
BDM suppressed the disassembly of the Golgi complex in-
duced by BFA (Figure 3, E–H and Q). To examine the
involvement of myosin II in this membrane route, we ana-
Figure 1. Double immunofluorescence microscopy experiments in
untreated (A and B) and BDM- (C–F) or ML7-treated NRK cells (G
and H) stained with anti-mannosidase II polyclonal antibodies (A,
C, E, and G) and TRITC-phalloidin (B, D, F, and H) to reveal the
Golgi-resident enzyme (Man II) and filamentous actin (F-actin),
respectively. Bar, 10 m.
Figure 2. Electron microscopy of the Golgi complex in untreated
(A) and BDM- (40 mM) or ML7 (30 M)-treated NRK cells (B and C,
respectively). Unlike control cells (A), BDM- (B) and ML7 (C)-
treated cells show a Golgi complex with swollen cisternae (B) and
numerous peri-Golgi vesicles. The latter are more evident after ML7
treatment (C), in which numerous peri-Golgi vesicles of uniform
size and close attachment to the Golgi cisternae are easily observed.
J.M. Dura´n et al.
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lyzed the effects of inhibiting MLCK by using ML7, and of
overexpressing nonmuscle myosin II regulatory light chain
(MRLC2) constructs. ML7 also produced a significant delay
in the BFA-induced Golgi complex disassembly (Figure 3,
I-L and Q), but its inhibitory effect was weaker than that
produced by BDM (Figure 3 Q). In addition to its effect on
MLCK, ML7 is also able to partially inhibit protein kinase
(PK) A and PKC enzymatic activities, albeit with a much
lower efficiency than for MLCK (Ki values of 21 M, 42 M,
and 300 nM, respectively). To examine whether PKA or PKC
Figure 3. Immunofluorescence microscopy experiments of the kinetics of the BFA-induced disassembly of the Golgi complex stained to Man
II in control (A–D), in BDM (20 mM)- (E–H), in ML7- (30 M) (I–L), and in Y-27642 (25 M)-treated NRK cell (M–P). A quantitative analysis
of these results is shown in Q. The results are the mean of two independent experiments; at least 200 cells, randomly chosen, were counted
per experimental condition. Note that the disassembly of the Golgi complex remained unaltered after treatment with the Rho kinase inhibitor
Y-27642, but was significantly delayed by ML7 treatment and practically blocked by BDM. Bar, 10 m.
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were also significantly involved in the retrograde pathway,
NRK cells were treated with H7 or H89 (30 M). Neither H7-
nor H89-treated cells altered the kinetics of the disassembly
of the Golgi complex induced by BFA (see supplementary
data). This suggests that neither PKA nor PKC is apparently
involved in the Golgi-to-ER pathway.
To gain further insight into the involvement of nonmuscle
myosin II, HeLa cells were transfected with either the re-
combinant myc-tagged MRLC2 wild-type (MRLC2wt) or
with a MRLC2 mutant that mimics its unphosphorylated
state, in which both Ser19 and Thr18 were substituted by Ala
(MRLC2AA; Iwasaki et al., 2001). The kinetics of the BFA-
induced Golgi disassembly was greatly slowed down in
cells expressing MRLC2AA (Figure 4 F, F to H, H), whereas
it remained unaltered in cells overexpressing the MRLC2wt
form (Figure 4 B, B to D, D). As expected, MRLC2AA
Figure 4. Kinetics of the BFA-induced disassembly of the Golgi complex stained to galactosyltransferase (galtase) in HeLa cells expressing
myc-MRLC2wt (A–D) or myc-MRLC2AA (E–H). MRLC2 expressing cells were identified by immunofluorescence staining with anti-myc
monoclonal antibodies (A–H) and the Golgi complex with anti-galtase polyclonal antibodies (A–H; asterisk indicates the corresponding
transfected cell). A quantitative analysis of these results is shown in I (the results are the mean of two independent experiments). Note that
the kinetics of the disassembly of the Golgi complex induced by BFA remains unaltered in cells expressing MRLC2wt, but was delayed in
MRLC2AA in comparison with neighboring nontransfected cells. Bar, 10 m.
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reduced the presence of actin stress fibers stained with cou-
marin-phalloidin (our unpublished data), and it was mostly
diffuse in the cytoplasm (Figure 4, E–H), whereas MRLC2wt
was mostly on actin stress fibers (Figure 4, A–D). Collec-
tively, the results strongly indicate that nonmuscle myosin II
is involved in the Golgi-to-ER pathway.
Next, we used Shiga toxin (ST-B) as a protein marker of
the Golgi-to-ER pathway. Unlike NRK, HeLa cells bind
Shiga toxin, which is transported to the ER via early endo-
somes and the Golgi complex (for review, see Sandvig and
van Deurs, 2000). Cells were treated as reported previously
and the toxin transport was imaged by confocal microscopy
(Valderrama et al., 2001). Briefly, cells were incubated at 4°C
with cy3-tagged fragment B of the toxin bearing the KDEL
sequence (ST-B-KDEL; Johannes et al., 1997) and, after 30
min, incubated at 19.5°C for 1 h to accumulate the internal-
ized toxin in the early/recycling endosomes. Subsequently,
cells were treated with or without BDM (40 mM; our un-
published data) or ML7 (30 M; Figure 6) and thereafter
they were transferred to 37°C to synchronize the retrograde
transport of Shiga toxin to the ER. In control cells (Figure 5,
A–H), ST-B-KDEL travels from early/recycling endosomes
(Figure 6A) via the Golgi complex (Figure 5, C–E) to the ER
(Figure 5G) giving rise to the characteristic ER-like staining
pattern as the toxin is retained. In contrast, in BDM- (our
unpublished data) and in ML7-treated cells (Figure 5, I–O),
after 6 h of transport, ST-B-KDEL was still clearly located in
the Golgi complex (Figure 5O).
We next studied putative changes in the ER-to-Golgi
membrane movement after myosin inhibition. To this end,
NRK or HeLa cells were first treated with BFA to induce the
fusion of Golgi membrane with ER, then incubated with
BDM/ML7, and subsequently BFA was withdrawn from the
culture medium. The rebuilding of the Golgi complex was
visualized by fluorescence microscopy by using anti-man-
nosidase II (Man II) antibodies. No differences were ob-
served in the kinetics of the reassembly of the Golgi complex
either in cells treated with BDM or ML7 or in those express-
Figure 5. Double confocal immunofluorescence microscopy experiments of the retrograde transport kinetics of the cy3-tagged Shiga toxin
fragment B containing the ER-retention signal KDEL (ST-B-Glyc-KDEL/ST-B-KDEL) in control (A–H) and ML7-treated HeLa cells (I–P).
Plasma membrane internalization of the ST-B-KDEL was performed at 19.5°C to accumulate it in early/recycling endosomes (A, B, I, and J).
Thereafter, cells were treated with ML7 (30 M) and treated and untreated cells were incubated to 37°C to trigger the transport of ST-B-KDEL
to the ER through the Golgi complex, which was stained with anti-giantin monoclonal antibodies (B, D, F, H, J, L, N, and P). Notice that after
6 h, unlike in control cells (G and H), in ML7-treated cells (O and P) ST-B is still significantly located in the Golgi complex (O and P). Bar,
10 m.
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ing the MRLC2AA mutant (our unpublished data). In addi-
tion, we assayed the ER-to-Golgi transport of the VSV-G
protein by fluorescence microscopy with anti-VSV-G protein
(Figure 6). Briefly, after infection of cells with ts045 mutant
VSV, the cells were kept at nonpermissive temperature
(40°C), at which the VSV-G protein is synthesized but re-
tained in the ER, and then treated with BDM or ML7. Cells
were shifted to the permissive temperature (32°C) and the
intracellular location of VSV-G protein was monitored by
fluorescence microscopy with an anti-VSV-G monoclonal
antibody. Neither BDM (Figure 6) nor ML7 (our unpub-
lished data) altered the transport of VSV-G protein from ER
to the Golgi complex.
Taken together, the data strongly indicate that only myo-
sins, and in particular nonmuscle myosin II, are involved in
the Golgi-to-ER membrane pathway.
Neither BDM nor ML7 Alters the BFA-induced
Coatomer Detachment or Tubule Formation
Treatment of cells with BFA leads to the formation of tubu-
lar extensions that have been implicated in the backflow of
Golgi components to the ER. These tubules connect the two
compartments and mediate the movement of Golgi lipids
and proteins to the ER membranes where their membranes
finally merge (Sciaky et al., 1997). Because myosin II has been
reported to be involved in the formation of vesicular carriers
from the TGN (Mu¨sch et al., 1997; Stow et al., 1998), we
analyzed whether the formation of tubules from the Golgi
complex induced by BFA was impaired by BDM or ML7.
However, the first morphological event that is visualized in
cells treated with BFA is the release of COP components,
such as -COP from Golgi membranes, which is required for
the redistribution of Golgi membranes into the ER (Donald-
son et al., 1990; Scheel et al., 1997). Thus, it is conceivable that
BDM and ML7 inhibit the BFA-mediated retrograde flow
from the Golgi complex to the ER by inhibiting the release of
coatomer from the Golgi complex. Therefore, we first carried
out an immunofluorescence study using an anti--COP an-
tibody on cells pretreated with BDM/ML7 or expressing
MRLC2WT/MRLC2AA. BFA-induced release of -COP from
the Golgi complex was unaffected by BDM or ML7 (Figure 7,
G and K, respectively) or MRLC2WT/AA (our unpublished
data). Regardless of whether cells were preincubated with
BDM before BFA treatment or both agents were added
simultaneously (see below), -COP release was indistin-
guishable from that in cells treated with BFA alone (Figure
7C). -COP was released at BFA incubation times, in which
the Golgi complex remained morphologically unaffected
(Figure 7, H and L), and neither BDM nor ML7 (Figure 7, E
and I) nor MRLC2WT/AA (our unpublished data) affected the
distribution of the coatomer component.
We next analyzed the kinetics of the appearance of tubules
from the Golgi complex when BDM- or ML-7–treated cells
were incubated with low concentrations of BFA (Figure 8).
After 4 min of BFA treatment, the tubules were seen in both
control and pretreated cells with BDM and ML7 (Figure 8, B,
F, and J). After 6 min, the tubules were still visible in
BDM/ML7-pretreated cells (Figure 8, G and K), although
the characteristic ER-like staining pattern was already ob-
served in some control cells (our unpublished data). After 10
Figure 6. NRK cells were infected with the VSV ts045 temperature-sensitive mutant virus and after accumulation at 40°C VSV-G
glycoprotein was monitored at immunofluorescence level with anti-VSV-G antibodies. Note that the kinetics of transport of VSV-G from the
ER to the Golgi complex (stained to Man II) is the same in untreated (A, C, and E) and ML7-treated cells (G, I, and K). Bar, 10 m.
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min, most of the BDM- or ML7 plus BFA-treated cells still
showed Man II-containing tubules and a Golgi structure was
still clearly recognizable (Figure 8, H and L), whereas all the
control BFA-treated cells showed the expected ER-like stain-
ing pattern for Man II (Figure 8D). The percentage of cells
that showed Golgi-emerging tubules induced by BFA was
unaltered by BDM or ML-7 treatments, but the tubules
remained longer in the cytoplasm before their fusion with
ER membranes (Figure 8M). Similarly, in MRLC2AA-trans-
fected and BFA-treated cells, long Golgi-derived tubules
were still visualized when their neighboring nontransfected
cells already displayed the characteristic ER-like staining
pattern (Figure 4, G and H).
BDM/ML7-induced Alteration in Golgi-to-ER
Membrane Backflow Is Not Produced by Depletion
of Intracellular Ca2 Stores
Although BDM affects the actomyosin system and inhibits
myosin ATPase in vitro (Higuchi and Takemori, 1989; Herr-
mann et al., 1992; Cramer and Mitchison, 1995) and in vivo
(Cramer and Mitchison, 1995; Lin et al., 1996; Gloushankova
et al., 1998; Steinberg and McIntosh, 1998), it has also been
reported that BDM affects intracellular calcium concentra-
tion (Steinberg and McIntosh, 1998, and references therein).
This reported collateral effect of BDM on intracellular cal-
cium levels (in particular when it is used at higher concen-
trations of 30 mM; Phillips and Altschuld, 1996) could be
relevant because the sequestration of Ca2 to intracellular
stores is required for the anterograde and retrograde trans-
port between the ER and the Golgi complex (Beckers and
Balch, 1989; Ivessa et al., 1995; Chen et al., 2002). Thus, to test
whether the observed effects on the disassembly of Golgi
induced by BDM or ML7 were the result of alterations in
calcium homeostasis, we monitored in vivo the cytoplasmic
calcium release from intracellular stores. HeLa cells were
loaded with Fluo 4/AM and the fluorescence ratio was
continuously monitored under the confocal microscope (Fig-
ure 9). Unlike ML7 (Figure 8C), BDM induced a small bi-
phasic rise in [Ca2]i (1.34  0.02; Figure 9, A and B). To
assess the relative contribution of BDM to the [Ca2]i in-
crease from the total Ca2 from intracellular stores, cells
were subsequently treated with thapsigargin, a selective
inhibitor of the ER Ca2-ATPase, a pump that maintains a
high concentration of Ca2 in the lumen of the ER (Thastrup
et al., 1990). When thapsigargin was added 1.5 min after
BDM, a much larger and monophasic rise in [Ca2]i was
registered (4.1  0.11; Figure 9A). When thapsigargin was
added 30 min after BDM, a smaller peak was also observed
but it lasted much longer (Figure 9B). After ML7 treatment,
thapsigargin induced a small monophasic transient increase
in [Ca2]i (2.1  0.06; Figure 9C) regardless of the time
Figure 7. NRK cells were pretreated for 30 min with BDM (20 mM; E, F, G, and H) or ML7 (30 M; I, J, K, and L), and subsequently
incubated with BFA (2 g/ml) for 60 s (C, D, G, H, K, and L). Thereafter, cells were fixed and processed for immunocytochemical
double-staining by using antibodies against -COP (A, E, I, C, G, and K) and to Man II (B, F, J, D, H, and L). Note that BDM and ML7 do
not interfere with BFA-induced -COP release (G and K) and they do not cause its release by themselves (E and I). Bar, 10 m.
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interval used between the two compounds. Taking these
results into account, we examined whether the effect of BDM
on the disassembly of the Golgi complex induced by BFA
was reproduced when cells were pretreated with BDM for
only 1–2 min or when BDM and BFA were added simulta-
neously. In both experimental conditions, BDM suppressed
the effect of BFA (our unpublished data). Thus, the inhibi-
tion of the BFA-induced Golgi disassembly produced by
BDM and ML7 is not merely the result of an alteration in
calcium homeostasis.
Rho-Kinase Does Not Play a Role in Myosin II-
based Golgi-to-ER Transport
Activation of myosin II via phosphorylation of the light
chain can be regulated not only by MLCK but also by Rho
kinase, which, in turn, is activated by RhoA-GTP directly
phosphorylating MLC at Ser 19 or via inactivation of myosin
phosphatase (Amano et al., 1996; Kimura et al., 1996; Kure-
ishi et al., 1997). To test whether Rho-dependent signaling, in
addition to MLCK, plays a role in retrograde transport, we
assayed BFA-induced Golgi complex disassembly in cells that
had been pretreated with Y-27632, a selective inhibitor of Rho-
kinase (Uehata et al., 1997), at concentrations of 25 and 50 M.
Under these conditions, Y-27632 induced the disappearance of
actin stress fibers (our unpublished data), but the Golgi com-
plex morphology and the kinetics of the disassembly of the
Golgi complex induced by BFA remained unaltered (Figure 3,
M–Q). Thus, Rho-kinase does not play a role in myosin II
activation during the Golgi-to-ER membrane flow and this
activation is largely regulated by MLCK alone.
PIP5K-induced Actin Comets Mediate Neither in the
Endocytic nor in the Golgi-to-ER Transport of ST-B
Activated Cdc42 regulates retrograde transport via
N-WASP, which is recruited to the Golgi complex (Luna et
al., 2002). This suggests that an actin-based propulsion of
transport carriers from Golgi to the ER is possible. To ex-
plore this possibility, we overexpressed myc-tagged PIP5K
isotype I in cells by microinjection of its cDNA into the
nucleus of HeLa cells, producing the appearance of filamen-
Figure 8. NRK cells were pre-
treated with BDM (20 mM) or ML7
(30 M) for 60 min and subse-
quently incubated with BFA (2 g/
ml); at indicated times cells were
fixed and stained for Man II. After
10 min, unlike BFA-treated cells
alone (D), BDM/ML7-treated cells
still showed Golgi-emerging tu-
bules after BFA treatment (H and
L, respectively). Notice that at ear-
lier times (4 and 6 min) of BFA
treatment both untreated and
BDM/ML7-treated cells showed
the normal appearance of BFA-in-
duced tubules. A quantitative vali-
dation of these morphological ob-
servations is shown in M. This
quantification is the mean of two
independent experiments, 200 cells
being counted in each one. Bar, 10
m.
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tous actin-containing comets as early as after 1 h of expres-
sion. To examine whether endocytic transport carriers were
present at the heads of these actin comets, cells were first
microinjected with PIP5K and, after 1–2 h of expression, they
were incubated at 4°C with native Shiga toxin fragment B
(ST-B). Subsequently, cells were washed and transferred to
37°C for short internalization times before chemical fixation
(Figure 10). Confocal images showed that ST-B was not
present at the heads of actin comets (Figure 10, A and A).
Next, we examined the membrane pathway from the Golgi
complex to the ER. Cells were incubated with ST-B at 4°C for
30 min, washed, internalized at 37°C (at this temperature,
ST-B shows a steady-state distribution at the Golgi complex,
although it continuously and rapidly cycles through the ER),
and finally PIP5K DNA was microinjected into the nucleus.
Again, no transport carrier-containing ST-B colocalized with
the head of actin comets (Figure 10, B and B). PIP5K ex-
pression times longer than 3 h were unsatisfactory because
the Golgi complex seemed extensively fragmented (our un-
published data). Taken together, these results strongly sug-
gest that PIP5K-induced actin comets do not propel ST-B–
containing transport carriers.
DISCUSSION
We have recently reported that actin facilitates Golgi-to-ER
protein transport. Actin is present in the lateral rims of Golgi
cisternae and in Golgi-derived transport intermediates
(Valderrama et al., 2000, 2001). In the present study, we have
examined the mechanism supporting this physiological role
of actin in trafficking between the ER and the Golgi. Cur-
rently, there are two possibilities; this involves either the
actin-based motors or actin comets. We have tested which of
these two processes is physiologically relevant in cultured
mammalian cells, assuming that simultaneous action of both
mechanisms in the Golgi-to-ER protein transport is unlikely.
We used pharmacological and molecular experimental ap-
proaches to inhibit myosin motor activity or to generate
actin comets. Our results can be summarized as follows:
only the retrograde Golgi-to-ER pathway is inhibited when
myosin motors are impaired; this alteration is not caused by
changes in calcium homeostasis; and ST-B is not observed in
the actin comet head at any time during its transport from
the plasma membrane to the ER via the Golgi complex.
Collectively, our results indicate that myosin motors and not
actin comets are mediators of the actin-based Golgi-to-ER
protein transport.
Actin-based Motors and Nonmuscle Myosin II in
Golgi-to-ER Pathway
Myosins have been implicated in vesicular transport (for
review, see Allan and Schroer, 1999). In particular, using
BDM and a monoclonal antibody (AD7), it was reported that
myosin II is involved in the formation of transport interme-
diates at the TGN (Mu¨sch et al., 1997). However, this result
has been challenged by Simon et al. (1998), mainly because of
the specificity of this antibody (see Stow et al., 1998 for
details). Additional experimental evidence that myosin II is
the vesicle motor has been obtained by through use of ML7,
a selective inhibitor of MLCK (Ruchhoeft and Harris, 1997).
Inhibition of MLCK by ML7 blocks vesicle movement, pre-
Figure 9. Representative traces showing the effect of BDM (20
mM) and ML7 (30 M) on intracellular calcium release in NRK cells.
F4/AM-loaded cells were exposed to BDM (A and B) and ML7 (C).
Notice that, unlike ML7, BDM induced a small and transient bipha-
sic peak of [Ca2]i release. When thapsigargin (5 M) was subse-
quently added after 90 s (A) or 20 min (B), a second wave of [Ca2]i
release was produced.
Myosins in Retrograde Protein Transport
Vol. 14, February 2003 455
sumably by inhibiting the activity of myosin II (for review,
see DePina and Langford, 1999). Hence, ML7 is a good
reagent to test the involvement of myosin II in the biological
processes examined. Herein, we observed that impairment
in the BFA-induced disassembly of the Golgi complex is
much more severe when cells are pretreated with BDM than
with ML7. BDM could produce the higher inhibitory effect
because of the simultaneous inhibition of several myosins
(see below). The results with ML7 confirm those observed
with BDM, but with the additional advantage that ML7
produced no alterations in the levels of intracellular calcium
and was also more restrictive in the molecular target (myo-
sin II). In this regard, the unaltered kinetics in the Golgi
disassembly induced by BFA in cells treated with H89 and
H7 suggest that neither PKA nor PKC are apparently in-
volved in the Golgi-to-ER pathway. This is in accordance
with the findings of Lee and Linstedt (2001), which despite
the observation that the redistribution of Golgi residents to
the ER was inhibited by H89 (at 50 M), they discarded that
PKA was the kinase required for the bidirectional transport
at the ER/Golgi interface, because a number of other protein
kinase inhibitors at concentrations reported to inhibit PKA
and PKC (120 M H8; 9 M KT5720; 60 M H7) inhibited
neither the retrograde nor anterograde transport. Thus, the
use of ML7 at concentrations that are widely used in vivo are
indicative that myosin II is involved in the retrograde pro-
tein transport. This was confirmed using a mutant of the
nonmuscle myosin II regulatory light chain (MRLC2AA) that
cannot be phosphorylated. Cells transfected with this mu-
tant showed similar perturbation in the Golgi disassembly
induced by BFA treatment as that observed in ML7-treated
cells (Figures 4 and 3, respectively). However, myosin II is
neither a resident Golgi protein (Narula et al., 1992; de
Almeida et al., 1993) nor a processive motor. These proper-
ties constrain its mode of action at the Golgi, and for this
reason it has been suggested that the myosin II tail partici-
pates only in the budding of transport carriers (Stow et al.,
1998). Consequently, this assumption and the observation
Figure 10. Merged images of PIP5K-overexpressed HeLa cells stained with fluorescein isothiocyanate-phalloidin (green) and cy3-ST-B (red).
In A–A and B–B, the transport route from the plasma membrane to early/recycling endosomes for ST-B and the Golgi-to-ER transport of
ST-B were examined. Actin comets generated by overexpressing PIP5K were identified (white arrows). Notice that no association staining for
two markers are observed in either of the experimental conditions, suggesting that actin comets do not propel ST-B at any stage of its
internalization process to the ER. Bar, 10 m.
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that the delay in the Golgi disassembly induced by BFA is
much more severe in BDM- than in ML7-treated cells, sug-
gest the participation of a second (processive) motor that
subsequently helps move the newly generated transport
carriers to their final destination (in this case the ER). In this
respect, myosins V and VI are processive motors (which
means that it takes successive steps along the actin filament)
that are reported to be located in the Golgi complex and
involved in vesicular trafficking in some cell types (Nasci-
mento et al., 1997; Buss et al., 1998; DePina and Langford,
1999; Miller and Sheetz, 2000; Schott et al., 2002; da Silva
Bizario et al., 2002) and, thus, they could be acting in tandem
with myosin II at the Golgi complex. However, we cannot
completely rule out the sole implication of myosin II, be-
cause despite that this motor does not take successive steps
along the actin filament, multiple myosin II moieties could
show successive steps along a filament (a processive move-
ment). This can occur if a second myosin II motor binds the
filament before the first motor releases (Howard, 2001).
The observation that the emergence of tubules from the
Golgi induced by BFA remains unaltered in BDM/ML7-
treated cells suggests that actin motors are not directly in-
volved in the formation of these tubules. Interestingly, BFA-
induced tubules remain longer in the cytoplasm before their
fusion with the ER. In addition, EM data suggest that myo-
sin II is not directly involved in budding, because in ML7-
and, to a lesser extent, BDM-treated cells, there is a signifi-
cant accumulation of peri-Golgi vesicles (Table 1; Figure 2C),
probably because they remain blocked in their movement to
the ER once they have been formed at the lateral rims of the
Golgi complex.
Taken together, these observations lead to the following three
possibilities: 1) myosins are only involved in the locomotion pro-
cess of transport carriers. Consequently, their inhibition delays the
arrival of Golgi-derived transport carriers to putative ER entering
sites; 2) transport carriers are normally transported via microtu-
bules to the vicinity of these ER entering sites, but cannot be
efficiently translocated to actin filaments, and their fusion to the
ER is, therefore, delayed. Simultaneously, the BFA-induced tu-
bules are continuously growing from the Golgi and become
longer compared with those observed in control cells. This possi-
bility suggests the presence of actin cytoskeleton and myosin
motors associated with ER. The former has been reported in
photoreceptor cells and in the corneal epithelium (Svoboda and
Hay, 1987; Baumann and Lautenschlager, 1994); the latter is the
case of myosin V, which is involved in the ER transport into the
dendritic spines of neuronal cells (Tabb et al., 1998; Molyneaux et
al., 2000). However, we are not inclined for this possibility because
first, we have not observed a significant association of /-actin
isoforms with ER membranes at the ultrastructural level by using
monospecific polyclonal antibodies (J.A. Martı´nez-Mena´rguez
and G. Egea, unpublished data); second, ST-B-KDEL is retained in
the Golgi complex of cells with disrupted myosin function; and
third, transport carriers are captured by peri-Golgi actin filaments
via myosin motors as soon as they are formed at the lateral rims
of Golgi cisternae. Subsequently, transport carriers are translo-
cated to the microtubules for their movement to the ER. The
presence of actin isoforms in Golgi-derived buds and vesicles
(Valderrama et al., 2000) and the accumulation of ST-B in the Golgi
complex either when actin filaments are disrupted (Valderrama et
al., 2001) or myosin function is inhibited (this study) strongly
support this possibility.
No Actin Comets in Golgi-to-ER Pathway
Plasma membrane and endomembranes are able to recruit
N-WASP-Arp2/3 that could trigger focalized actin polymer-
ization (actin tail), which in turn acts as a driving force for
the locomotion of transport carriers or organelles (Merrifield
et al., 1999, 2001; Rozelle et al., 2000; Taunton et al., 2000; Lee
and De Camilli, 2002; Benesch et al., 2002; Orth et al., 2002).
Most of studies that report actin comets associated with
endo/exocytic transport vesicles use cells that overexpress
PIP5K (Rozelle et al., 2000; Benesch et al., 2002; Lee and De
Camilli, 2002; Orth et al., 2002). Using this same experimen-
tal approach, our results clearly show that transport carriers
containing ST-B are not visualized at the head of actin tails
during trafficking from plasma membrane to the ER (Figure
10). Nonetheless, small and short-lived actin comets could
be generated concomitantly to the formation of transport
carriers at the lateral rims of the Golgi, facilitating their final
scission or separation from the cisternae. However, this
possibility seems unlikely because the retrograde transport
of ST-B and Golgi enzymes remained unaltered in cells
expressing a truncated form of N-WASP lacking the Arp2/3
binding site and, therefore, unable to form actin comets
(Luna et al., 2002). These results, together with the previous
observation that VSV-G is rarely associated with actin com-
ets (Rozelle et al., 2000), strongly indicate that actin comets
do not propel transport carriers at the ER/Golgi interface.
In conclusion, our findings indicate that retrograde trans-
port carriers use actin-based motors, most likely myosin II in
their trafficking from Golgi membranes to the ER.
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